The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Luncheon Seminar

LS1-13

The potential of HEMLIBRA® for hemophilia A patients with inhibitors.

Fri. Oct 12, 2018 12:15 PM - 1:00 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Satoshi Higasa (Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan)

Sponsor: Chugai Pharmaceutical Co., Ltd.

[LS1-13] The potential of HEMLIBRA® for hemophilia A patients with inhibitors.

Takashi Suzuki (Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan)